L-Lactate reprograms tumor-associated macrophages to drive pancreatic cancer progression via BCL3 lactylationPeixuan Ji, Yong-Wei Sun|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0
Chiglitazar in combination with anti-inflammatory and hepatoprotective therapy for the treatment of MASH associated with T2DM: a prospective, multicentre, randomised, double-blind, placebo-controlled study protocolKai He, Hui Li, Rong Shao et al.|BMJ Open|2026Cited by 0